Wg. Mayhan et al., EFFECT OF L-ARGININE ON REACTIVITY OF HAMSTER-CHEEK POUCH ARTERIOLES DURING DIABETES-MELLITUS, International journal of microcirculation, clinical and experimental, 17(3), 1997, pp. 107-112
The goal of this study was to determine whether exogenous application
of L-arginine could restore impaired agonist-induced increases in arte
riolar diameter during diabetes mellitus. We used intravital microscop
y to examine reactivity of cheek pouch arterioles (50 mu m in diameter
) in nondiabetic and diabetic (2 weeks after injection of streptozotoc
in) hamsters in response to histamine and substance P. In nondiabetic
hamsters histamine (1.0 and 5.0 mu M) dilated cheek pouch arterioles b
y 15 +/- 1 and 22 +/- 1%, respectively, and substance P (50 and 100 nM
) dilated arterioles by 14 +/- 3 and 21 +/- 4%, respectively. In addit
ion, dilatation of arterioles in response to histamine and substance P
in nondiabetic hamsters was abolished by application of an enzymatic
inhibitor of nitric oxide synthase (L-NMMA). In contrast, histamine- a
nd substance P-induced increases in arteriolar diameter were markedly
reduced in diabetic hamsters. Histamine (1.0 and 5.0 mu M) dilated art
erioles by only 5 +/- 1 and 4 +/- 2%, respectively, and substance P (5
0 and 100 nM) dilated arterioles by only 6 +/- 2 and 5 +/- 3%, respect
ively (p < 0.05 vs. nondiabetic hamsters). Nitroglycerin produced simi
lar vasodilatation in nondiabetic and diabetic hamsters. Next, we exam
ined whether exogenous application of L-arginine (100 mu M) could rest
ore impaired histamine-and substance P-induced increases in arteriolar
diameter in diabetic hamsters. We found that L-arginine did not resto
re altered nitric oxide synthase-dependent vasodilatation in diabetic
hamsters. These findings suggest that short-term diabetes mellitus alt
ers agonist-induced increases in arteriolar diameter. In addition, the
mechanism of altered arteriolar reactivity during diabetes mellitus d
oes not appear to be related to an impaired availability of L-arginine
.